​Underserved market hiding in plain sight: rural hospital drug shortages

2024 hit a 30-year high for active drug shortages in the US. Not niche stuff — saline, anesthetics, chemo drugs. The basics.

The whole system is absurdly fragile. Manufacturing is concentrated in just a few places globally, so one bad factory in India and suddenly ICUs across the country are rationing supplies.

Here’s the thing though — the FDA actually created a fix for this. It’s called a 503B Outsourcing Facility. Licensed compounding facilities that can make sterile drugs at scale and ship directly to hospitals. Built exactly for this problem.

So why are shortages still getting worse?

I looked at where these facilities are located. Almost entirely Texas, Florida, California. And they all require massive minimum orders that work great for huge hospital networks — and are completely useless for a 25-bed rural hospital in Montana.

Nearly half of US hospitals are rural or critical access. When shortages hit, the big facilities serve their largest clients first. The small rural hospital gets zero. Surgeries get cancelled.

The gap seems almost embarrassingly obvious. Build a regional 503B targeting rural hospitals specifically. Lower minimums, focused region, charge a premium because you’re literally the only option. Hospitals WILL pay it.

The barrier to entry is brutal — but that’s exactly what makes it so defensible once you’re in.